| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +8% |
| 3Y CAGR | +3% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +311% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,841.80 +27.80 (0.73%) | 17,449.79 | 20.31 | 3.98 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,085.30 -161.80 (7.20%) | 17,110.99 | 24.44 | 4.38 | ||
Natco PharmaNATCOPHARM | ₹820.60 -2.30 (0.28%) | 16,180.91 | 19.51 | 1.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,043.50 -124.50 (2.02%) | 15,415.50 | 86.74 | 17.54 |